Regeneron

About Regeneron

Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.

Explore similar firms in the Pharmaceuticals

Email Format

{first_name}.{last_name}@regeneron.com — 100.0%

sarah.smith@regeneron.com

Key Employees

Contact details of 11 Regeneron executives

Petra Rietschel

Senior Director Clinical Development ImmunoOncology
  • Work email

    p*************l@regeneron.com

Lisa Flanagan

Director, Patent Attorney- Therapeutics IP
  • Work email

    l***********n@regeneron.com

David Weinreich

Executive Vice President, Head, Global Clinical Development

Nanita Cranford

Executive Director, Head of Global Regulatory Operations

Aris Baras

Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center

Gregory Geba

Senior Vice President, Global Development Scientific Council

Neil Stahl

SVP Research and Development Sciences

Ned Braunstein

Senior Vice President, Regulatory Affairs

Eric Shooter

Founder

George D. Yancopoulos

Founder

Leonard S. Schleifer

Founder

Other Employees

Contact details of 14 Regeneron other employees

Boris Gorovits

Job not specified
  • Work email

    b************s@regeneron.com

Jacky Space

Job not specified
  • Work email

    j**************e@regeneron.com

Catherine Armstrong Bccl

Job not specified
  • Work email

    c************l@regeneron.com

Mena Soliman

Job not specified
  • Work email

    m**********n@regeneron.com

Heather Hammond

Job not specified
  • Work email

    h*************d@regeneron.com

Sarah Ghosh

Job not specified
  • Work email

    s*********h@regeneron.com

Sofia Caruso

Job not specified
  • Work email

    s**********o@regeneron.com

Jimmy Sanders

Job not specified
  • Work email

    j***********s@regeneron.com

Madison Lee

Job not specified
  • Work email

    m*********e@regeneron.com

Joseph Brown2

Job not specified
  • Work email

    j***********2@regeneron.com

Chenguang Wang

Job not specified
  • Work email

    c************g@regeneron.com

Rena Goins

Job not specified
  • Work email

    r********s@regeneron.com

Michael Selzer

Manager, Combination Products Engineering

Nouhad Husseini

Business Development

General Emails

General company emails, e.g. customer support lines

    thomas.daly@regeneron.com

    Unclassified inbox

    david.glass@regeneron.com

    Unclassified inbox

Similar Companies like Regeneron

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical Pharmaceuticals

Legal Name: AbbVie Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical Pharmaceuticals

Legal Name: Pfizer Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

HQ: Rahway, New Jersey, United States

Merck

merck.com

Merck is a biopharmaceutical company that offers medicines a...

HQ: Rahway, New Jersey, United States

Specialized In: Biotechnology, Healthcare & Medical Pharmaceuticals

Legal Name: Merck & Co., Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Equity

Last Investment Activity: Mar 28, 2024

Founded Date: 1891

Number of Exits: 9

Company Type: For Profit

Stock Symbol: NYSE:MRK

Operating Status: Active

Company Info

Last updated: 31/07/2025

+118557343648

Tarrytown, New York, United States

Regeneron General Information

Specialization: Pharmaceuticals, Biotechnology
Legal Name: Regeneron Pharmaceuticals, Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Venture Stage: Early Stage Venture
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +118557343648
Last Investment Activity: Sep 6, 2024
Investments Activity: Sep 6, 2024 Sep 4, 2024 Sep 4, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.